Association of chemotactic factor receptor 5 gene with breast cancer

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 5289-5300

  Zhang, Y ^a   Meng, F Y ^b   Li, W L ^a   Zhou, C X ^a   Guan, Z ^a   Fan, H Y ^b  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b Medical College of Liaocheng Vocational and Technical School   (China)

Author keywords

Breast cancer; C erbB 2; CCR5; Immunohistochemistry; Ki 67; Prognostic indicator

Indexed keywords

CHEMOKINE RECEPTOR CCR5; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; PARAFFIN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER TISSUE; CHEMOTACTIC FACTOR RECEPTOR 5 GENE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BREAST NEOPLASMS; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; RECEPTORS, CCR5; RISK FACTORS; RNA, MESSENGER;

EID: 84887335475     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.November.7.4     Document Type: Article

References (13)

1. Azenshtein E, Luboshits G, Shina S, Neumark E, et al. (2002). The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res. 62: 1093-1102.
2. Balkwill F (2003). Chemokine biology in cancer. Semin. Immunol. 15: 49-55.
3. Degerli N, Yilmaz E and Bardakci F (2005). The delta32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population. Clin. Biochem. 38: 248-252.
4. Frederick MJ and Clayman GL (2001). Chemokines in cancer. Expert Rev. Mol. Med. 3: 1-18.
5. Karnoub AE, Dash AB, Vo AP, Sullivan A, et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
6. Li WL, Zhang Y, Meng FY, (2009). Changes in the expression of CCR5 and infiltrating ductal breast cancer axillary lymph node metastases [J]. Shandong Med. 49: 19-20.
7. Loetseher PM, Ugueeioni L, Bordoi M, (1998). CCR5 15 character is tie of Thl lymphocytes. Nature 391: 344-348.
8. Mañes S, Mira E, Colomer R, Montero S, et al. (2003). CCR5 expression influences the progression of human breast cancer in a p53-dependent manner. J. Exp. Med. 198: 1381-1389.
9. Muller A, Homey B, Soto H, Ge N, et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
10. Tan C, Yi CH and Li JJ (2009). Human breast cancer stem cells, CCR5 expression and its significance. Wuhan Univ. J. Nat. Sci. 20: 379-382.
11. Wang D, Guo MY and Guo BY (2005). Chemokine receptor 5 expression in infiltrating ductal breast cancer tissue and its significance. Acta Sec. Mil. Med. Univ. 25: 657-659.
12. Wei W, Yao F and Tu Y (2007). Breast tissue chemoattractant factor 5 expression and its clinical significance. J. Cancer Prev. Treat. 14: 1475-1479.
13. Zlotnik A and Yoshie O (2000). Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127.